Icahn School of Medicine at Mount Sinai’s 29th annual Convocation Ceremony, held Monday, September 29, honored 10 physician-scientists whose groundbreaking achievements have made them leaders in the fields of cancer, HIV/AIDs, immunology, microbiology, ophthalmology, psychiatry, rheumatology, surgery, and urology.
Amid much jubilation, 140 first-year students at Icahn School of Medicine at Mount Sinai symbolically marked the start of their medical education by receiving white coats and stethoscopes at the 17th Annual White Coat Ceremony held Monday, September 8.
“Some members of the Class of 2018 will make scientific discoveries that will improve our ability to diagnose and treat patients, while others will become master clinicians and educators, or focus on improving public health for underserved communities around the world,” Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai and President for Academic Affairs, Mount Sinai Health System, told the students. “The medical path you choose must be powered by idealism. We will nurture your idealism—because at Mount Sinai we translate idealism into action for the betterment of patients everywhere.”
Faculty from throughout the Mount Sinai Health System joined residents, and medical and graduate students, at a recent social event sponsored by Friends of Odysseus, a black male mentoring program established in 2012 at the behest of Mount Sinai leadership to assist with the recruitment, retention, and promotion of black and Hispanic males in the sciences and medicine.
Mount Sinai leaders saluted the more than 1,200 volunteers who support The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai during a recent breakfast held to honor their commitment and dedication.
Following a performance by two volunteer flutists from the Music for Healing program, Peter W. May, Chairman, Boards of Trustees, Mount Sinai Health System, told guests: “There is a broad range of individuals who help Mount Sinai. While some have the capability to support us financially, many more give their valued time, spirit, and compassion to help patients, families, and staff. We salute your enthusiasm and accomplishments.”
Ketamine, a drug approved for use as a general anesthetic and sedative, also appears to provide significant relief to patients with major depressive disorder, and those with chronic post-traumatic stress disorder (PTSD), according to two separate studies conducted by researchers at Icahn School of Medicine at Mount Sinai.
After launching a much-publicized campaign in October to promote the influenza vaccination for faculty, staff, and students, the Mount Sinai Health System will report a record rate of vaccination compliance to the New York State Department of Health (NYSDOH) for the 2013 – 2014 influenza season.
Typically, vaccination rates for health care workers are around 60 percent, according to the U.S. Centers for Disease Control and Prevention. The Health System’s overall compliance rate was 82 percent at the start of April.
One hundred twenty-seven members of Icahn School of Medicine at Mount Sinai’s Class of 2014 participated in the nation’s annual Match Day event on Friday, March 21. They gathered in the Annenberg West lobby to open their envelopes en masse and find out which residency programs they would be attending during the next phase of their training.
Icahn School of Medicine at Mount Sinai and The New York Academy of Medicine (NYAM) announced the formation of a new partnership to jointly study and address a number of significant health issues and policies that impact the lives of people who live in urban areas. NYAM is an historic and independent institution that has been advancing the health of people living in cities since its founding in 1847.